Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Arnold

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
The Canadian Journal of Cardiology|February 2, 2006
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trialE Lonn, C Held, J M O Arnold, et al.
Plos One|November 10, 2010
An outbreak of dengue fever in St. Croix (US Virgin Islands), 2005Hamish Mohammed, Mary Ramos, Julie Armstrong, et al.
JAMA|March 17, 2005
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trialEva Lonn, Jackie Bosch, Salim Yusuf, et al.
American Heart Journal|February 15, 2001
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysisY Aikawa, L Rohde, J Plehn, et al.
European Journal of Heart Failure|September 29, 2005
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM ProgramGary F Mitchell, J Malcolm O Arnold, Mark E Dunlap, et al.
Hypertension (Dallas, Tex. : 1979)|December 12, 2007
Aortic diameter, wall stiffness, and wave reflection in systolic hypertensionGary F Mitchell, Paul R Conlin, Mark E Dunlap, et al.
Journal of the American College of Cardiology|October 18, 2003
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE studyEldrin F Lewis, Lemuel A Moye, Jean L Rouleau, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 2, 2006
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic studyJens Jakob Thune, Lars Køber, Marc A Pfeffer, et al.
Circulation|December 13, 1997
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trialM St John Sutton, M A Pfeffer, L Moye, et al.
American Heart Journal|August 1, 2006
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertensionRajesh Janardhanan, William L Daley, Tasneem Z Naqvi, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
The Canadian Journal of Cardiology|February 2, 2006
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trialE Lonn, C Held, J M O Arnold, et al.
Plos One|November 10, 2010
An outbreak of dengue fever in St. Croix (US Virgin Islands), 2005Hamish Mohammed, Mary Ramos, Julie Armstrong, et al.
JAMA|March 17, 2005
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trialEva Lonn, Jackie Bosch, Salim Yusuf, et al.
American Heart Journal|February 15, 2001
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysisY Aikawa, L Rohde, J Plehn, et al.
European Journal of Heart Failure|September 29, 2005
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM ProgramGary F Mitchell, J Malcolm O Arnold, Mark E Dunlap, et al.
Hypertension (Dallas, Tex. : 1979)|December 12, 2007
Aortic diameter, wall stiffness, and wave reflection in systolic hypertensionGary F Mitchell, Paul R Conlin, Mark E Dunlap, et al.
Journal of the American College of Cardiology|October 18, 2003
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE studyEldrin F Lewis, Lemuel A Moye, Jean L Rouleau, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 2, 2006
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic studyJens Jakob Thune, Lars Køber, Marc A Pfeffer, et al.
Circulation|December 13, 1997
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trialM St John Sutton, M A Pfeffer, L Moye, et al.
American Heart Journal|August 1, 2006
Rationale and design: the VALsartan In Diastolic Dysfunction (VALIDD) Trial: evolving the management of diastolic dysfunction in hypertensionRajesh Janardhanan, William L Daley, Tasneem Z Naqvi, et al.
Pageof 10